Literature DB >> 22628551

Ring finger protein 149 is an E3 ubiquitin ligase active on wild-type v-Raf murine sarcoma viral oncogene homolog B1 (BRAF).

Seung-Woo Hong1, Dong-Hoon Jin, Jae-Sik Shin, Jai-Hee Moon, Young-Soon Na, Kyung-Ah Jung, Seung-Mi Kim, Jin Cheon Kim, Kyu-Pyo Kim, Yong Sang Hong, Jae-Lyun Lee, Eun Kyung Choi, Jung Shin Lee, Tae Won Kim.   

Abstract

Members of the RAF family (ARAF, BRAF, and CRAF/RAF-1) are involved in a variety of cellular activities, including growth, survival, differentiation, and transformation. An oncogene encodes BRAF, the function of which is linked to MEK activation. BRAF is the most effective RAF kinase in terms of induction of MEK/ERK activity. However, the mechanisms involved in BRAF regulation remain unclear. In the present work, we used a tandem affinity purification approach to show that RNF149 (RING finger protein 149) interacts with wild-type BRAF. The latter protein is a RING domain-containing E3 ubiquitin ligase involved in control of gene transcription, translation, cytoskeletal organization, cell adhesion, and epithelial development. We showed that RNF149 bound directly to the C-terminal kinase-containing domain of wild-type BRAF and induced ubiquitination, followed by proteasome-dependent degradation, of the latter protein. Functionally, RNF149 attenuated the increase in cell growth induced by wild-type BRAF. However, RNF149 did not bind to mutant BRAF or induce ubiquitination thereof. Thus, we show that RNF149 is an E3 ubiquitin ligase active on wild-type BRAF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22628551      PMCID: PMC3390676          DOI: 10.1074/jbc.M111.319822

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Endothelial apoptosis in Braf-deficient mice.

Authors:  L Wojnowski; A M Zimmer; T W Beck; H Hahn; R Bernal; U R Rapp; A Zimmer
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

Review 2.  Active-site directed probes to report enzymatic action in the ubiquitin proteasome system.

Authors:  Huib Ovaa
Journal:  Nat Rev Cancer       Date:  2007-07-19       Impact factor: 60.716

Review 3.  RING domain E3 ubiquitin ligases.

Authors:  Raymond J Deshaies; Claudio A P Joazeiro
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

4.  Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases.

Authors:  R Marais; Y Light; H F Paterson; C S Mason; C J Marshall
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

Review 5.  Hyperactive Ras in developmental disorders and cancer.

Authors:  Suzanne Schubbert; Kevin Shannon; Gideon Bollag
Journal:  Nat Rev Cancer       Date:  2007-04       Impact factor: 60.716

6.  Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations.

Authors:  Jeeyun Lee; Inkyoung Lee; Boram Han; Joon Oh Park; Jiryeon Jang; Chaehwa Park; Won Ki Kang
Journal:  J Natl Cancer Inst       Date:  2011-03-11       Impact factor: 13.506

Review 7.  Ras signaling and therapies.

Authors:  Amy Young; Jesse Lyons; Abigail L Miller; Vernon T Phan; Irma Rangel Alarcón; Frank McCormick
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

8.  BRAF silencing by short hairpin RNA or chemical blockade by PLX4032 leads to different responses in melanoma and thyroid carcinoma cells.

Authors:  Elisa Sala; Luca Mologni; Silvia Truffa; Carlo Gaetano; Gideon E Bollag; Carlo Gambacorti-Passerini
Journal:  Mol Cancer Res       Date:  2008-05-05       Impact factor: 5.852

9.  PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells.

Authors:  Ruth Halaban; Wengeng Zhang; Antonella Bacchiocchi; Elaine Cheng; Fabio Parisi; Stephan Ariyan; Michael Krauthammer; James P McCusker; Yuval Kluger; Mario Sznol
Journal:  Pigment Cell Melanoma Res       Date:  2010-02-10       Impact factor: 4.693

10.  Identification of direct transcriptional targets of (V600E)BRAF/MEK signalling in melanoma.

Authors:  Leisl M Packer; Philip East; Jorge S Reis-Filho; Richard Marais
Journal:  Pigment Cell Melanoma Res       Date:  2009-08-04       Impact factor: 4.693

View more
  14 in total

1.  Exome Array Analysis of Nuclear Lens Opacity.

Authors:  Stephanie J Loomis; Alison P Klein; Kristine E Lee; Fei Chen; Samantha Bomotti; Barbara Truitt; Sudha K Iyengar; Ronald Klein; Barbara E K Klein; Priya Duggal
Journal:  Ophthalmic Epidemiol       Date:  2017-11-28       Impact factor: 1.648

Review 2.  Understanding the tumor microenvironment and radioresistance by combining functional imaging with global gene expression.

Authors:  Mark W Dewhirst; Jen-Tsan Chi
Journal:  Semin Radiat Oncol       Date:  2013-10       Impact factor: 5.934

3.  FUT11 as a potential biomarker of clear cell renal cell carcinoma progression based on meta-analysis of gene expression data.

Authors:  Elżbieta Zodro; Marcin Jaroszewski; Agnieszka Ida; Tomasz Wrzesiński; Zbigniew Kwias; Hans Bluyssen; Joanna Wesoly
Journal:  Tumour Biol       Date:  2013-12-08

4.  The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function.

Authors:  Lixin Wan; Ming Chen; Juxiang Cao; Xiangpeng Dai; Qing Yin; Jinfang Zhang; Su-Jung Song; Ying Lu; Jing Liu; Hiroyuki Inuzuka; Jesse M Katon; Kelsey Berry; Jacqueline Fung; Christopher Ng; Pengda Liu; Min Sup Song; Lian Xue; Roderick T Bronson; Marc W Kirschner; Rutao Cui; Pier Paolo Pandolfi; Wenyi Wei
Journal:  Cancer Discov       Date:  2017-02-07       Impact factor: 39.397

5.  The non-linearity of RAF-MEK signaling in dendritic cells.

Authors:  Kristina Riegel; Krishnaraj Rajalingam
Journal:  Cell Cycle       Date:  2020-08-04       Impact factor: 4.534

Review 6.  Ubiquitin ligases in oncogenic transformation and cancer therapy.

Authors:  Daniela Senft; Jianfei Qi; Ze'ev A Ronai
Journal:  Nat Rev Cancer       Date:  2017-12-15       Impact factor: 60.716

7.  TRAF1 Is Critical for Regulating the BRAF/MEK/ERK Pathway in Non-Small Cell Lung Carcinogenesis.

Authors:  Qiushi Wang; Ge Gao; Tianshun Zhang; Ke Yao; Hanyong Chen; Mi Hee Park; Hiroyuki Yamamoto; Keke Wang; Weiya Ma; Margarita Malakhova; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2018-05-10       Impact factor: 12.701

8.  RNF135, RING finger protein, promotes the proliferation of human glioblastoma cells in vivo and in vitro via the ERK pathway.

Authors:  Yongjian Liu; Feng Wang; Yongsheng Liu; Yiqun Yao; Xiupeng Lv; Bin Dong; Jun Li; Siyang Ren; Yiwen Yao; Yinghui Xu
Journal:  Sci Rep       Date:  2016-02-09       Impact factor: 4.379

9.  Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome.

Authors:  Hannah Steeb; Jordan M Ramsey; Paul C Guest; Pawel Stocki; Jason D Cooper; Hassan Rahmoune; Erin Ingudomnukul; Bonnie Auyeung; Liliana Ruta; Simon Baron-Cohen; Sabine Bahn
Journal:  Mol Autism       Date:  2014-01-27       Impact factor: 7.509

10.  Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles.

Authors:  Anja E Eisenhardt; Adrian Sprenger; Michael Röring; Ricarda Herr; Florian Weinberg; Martin Köhler; Sandra Braun; Joachim Orth; Britta Diedrich; Ulrike Lanner; Natalja Tscherwinski; Simon Schuster; Nicolas Dumaz; Enrico Schmidt; Ralf Baumeister; Andreas Schlosser; Jörn Dengjel; Tilman Brummer
Journal:  Oncotarget       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.